Cardiac Amyloidosis Therapy: A Systematic Review

被引:0
|
作者
Iodice, Franco [1 ]
Di Mauro, Marco [1 ]
Migliaccio, Marco Giuseppe [1 ]
Iannuzzi, Angela [1 ]
Pacileo, Roberta [1 ]
Caiazza, Martina [1 ]
Esposito, Augusto [1 ]
机构
[1] Univ Campania Luigi Vanvitelli, Dept Translat Med Sci, I-81100 Naples, Italy
关键词
cardiac amyloidosis; therapies amyloidosis; CHAIN AL AMYLOIDOSIS; LIGHT-CHAIN; P COMPONENT; PHARMACOLOGICAL DEPLETION; LIVER-TRANSPLANTATION; NATURAL-HISTORY; BENDAMUSTINE; IMPLANTATION; STABILIZER; DIAGNOSIS;
D O I
10.3390/cardiogenetics11010002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart involvement in Cardiac Amyloidosis (CA) results in a worsening of the prognosis in almost all patients with both light-chain (AL) and transthyretin amyloidosis (ATTR). The mainstream CA is a restrictive cardiomyopathy with hypertrophic phenotype at cardiac imaging that clinically leads to heart failure with preserved ejection fraction (HFpEF). An early diagnosis is essential to reduce cardiac damage and to improve the prognosis. Many therapies are available, but most of them have late benefits to cardiac function; for this reason, novel therapies are going to come soon.
引用
收藏
页码:10 / 17
页数:8
相关论文
共 50 条
  • [1] Mortality in Cardiac Amyloidosis: A Systematic Review and MetaAnalysis
    Jha, Mayank
    Harikrishna, Arya
    Al Hooti, Jubran
    Rehman, Muhammad Saad Ur
    Jain, Hritvik
    Mal, Madho
    Haider, Mobeen
    Hotwani, Priya
    Tummala, Nayanika
    Aamir, Muhammad
    Rajeswaran, Yasotha
    CIRCULATION, 2024, 150
  • [2] Conduction abnormalities and role of cardiac pacing in cardiac amyloidosis: A systematic review
    Alreshq, Rabah
    Tugal, Derin
    Siddiqi, Omar
    Ruberg, Frederick
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (12): : 2092 - 2099
  • [3] Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence-Based Recommendations
    Marques, Nuno
    Azevedo, Olga
    Almeida, Ana Rita
    Bento, Dina
    Cruz, Ines
    Correia, Emanuel
    Lourenco, Carolina
    Lopes, Luis Rocha
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (19):
  • [4] Cardiac Amyloidosis: A Contemporary Review of Medical and Surgical Therapy
    Brownell, Drew
    Pillai, Aiswarya J.
    Nair, Nandini
    CURRENT CARDIOLOGY REVIEWS, 2024, 20 (02) : 72 - 81
  • [5] Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review
    Gertz, Morie A.
    Dispenzieri, Angela
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (01): : 79 - 89
  • [6] Bridge to Transplant and Transplant Outcomes in Cardiac Amyloidosis: A Systematic Review
    Raftopulos, N.
    Gorrie, N.
    Bart, N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S248 - S248
  • [7] Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers
    Kyriakou, Panagiota
    Mouselimis, Dimitrios
    Tsarouchas, Anastasios
    Rigopoulos, Angelos
    Bakogiannis, Constantinos
    Noutsias, Michel
    Vassilikos, Vasileios
    BMC CARDIOVASCULAR DISORDERS, 2018, 18
  • [8] Outcomes of heart transplantation in cardiac amyloidosis: an updated systematic review
    Lakhdar, Sofia
    Buttar, Chandan
    Nassar, Mahmood
    Ciobanu, Camelia
    Patel, Rima
    Munira, Most Sirajum
    HEART FAILURE REVIEWS, 2022, 27 (06) : 2201 - 2209
  • [9] Artificial Intelligence as a Tool for Diagnosis of Cardiac Amyloidosis: A Systematic Review
    Ahmadi-Hadad, Armia
    De Rosa, Egle
    Di Serafino, Luigi
    Esposito, Giovanni
    JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING, 2024, 44 (04) : 499 - 513
  • [10] Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers
    Panagiota Kyriakou
    Dimitrios Mouselimis
    Anastasios Tsarouchas
    Angelos Rigopoulos
    Constantinos Bakogiannis
    Michel Noutsias
    Vasileios Vassilikos
    BMC Cardiovascular Disorders, 18